Onartuzumab (Synonyms: MetMAb) |
| Catalog No.GC69623 |
Onartuzumab (MetMAb) is a humanized, affinity-matured monoclonal antibody that inhibits the receptor tyrosine kinase MET. Onartuzumab effectively inhibits HGF binding, receptor phosphorylation and signal transduction. Onartuzumab has antibody-like pharmacokinetics and anti-tumor activity.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1133766-06-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Onartuzumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Onartuzumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *